Reduced prescription of TNF-inhibitors in chronic arthritis based on therapeutic drug monitoring: A randomized controlled trial.

Mogens Pfeiffer Jensen Donghua Liao U Tarp Bent Winding Deleuran Kristian Stengaard-Pedersen Jacob Venborg Birgitte Brock Christina Brock

Published in: Scandinavian journal of rheumatology (2022)

TDM reduced prescription of IFX, ETN, and ADA and identified patients benefiting from accelerated drug switch, thereby minimizing treatment failure, risk of toxicity, and unnecessary adverse events.

Keyphrases

rheumatoid arthritis
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
oxidative stress